Current Approaches and Emerging Directions in HER2-resistant Breast Cancer

Por Adam M. Brufsky
Publicado em 2014-01-01

Delaying Chemotherapy in the Treatment of Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Por Adam M. Brufsky
Publicado em 2015-12-01

Clinical-pathologic characteristics and response to neoadjuvant chemotherapy in triple-negative low Ki-67 proliferation (TNLP) breast cancers

Por Pooja Srivastava, Tiannan Wang, Beth Z. Clark, Jing Yu, Jeffrey L. Fine, Tatiana M. Villatoro, Gloria J. Carter, Adam M. Brufsky, Vikram C. Gorantla, Shannon L. Huggins-Puhalla, Leisha A. Emens, Thais Basili, Edaise M. da Silva, Jorge S. Reis-Filho, Rohit Bhargava
Publicado em 2022-04-01

Viewpoint: Origin of SARS-CoV-2

Por Kenneth Lundstrom, Murat Seyran, Damiano Pizzol, Parise Adadi, Tarek Mohamed Abd El-Aziz, Sk. Sarif Hassan, Antonio Soares, Ramesh Kandimalla, Murtaza M. Tambuwala, Alaa A. A. Aljabali, Gajendra Kumar Azad, Pabitra Pal Choudhury, Vladimir N. Uversky, Samendra P. Sherchan, Bruce D. Uhal, Nima Rezaei, Adam M. Brufsky
Publicado em 2020-10-01